Abstract
A range of isatin-thiazolidinone hybrid analogues were synthesized and their cytotoxicity was evaluated against several cancer cell lines in vitro. The acute toxicity studies in mice models revealed that these analogues possess low systemic toxicity and are safe up to 1600mg/Kg. Among the compounds synthesized, 5-(2-nitrobenzylidene)-2-(isatin-3- azino)-thiazolidin-4-one (CI) has been shown to be the most active, highly promising compound which induced S phase arrest in cell cycle in a time dependent manner. Our initial analysis indicate that incorporation of electron withdrawing group at ortho position of the ring favors over the meta and para positions for eliciting its cytostatic effect. Overall, the in vitro biological evaluation suggests that the growth inhibitory effect of CI is promising and can be studied further.
Keywords: Isatin, thiazolidinone, cancer, cytotoxicity, cell cycle arrest, Isatin-Thiazolidinone Hybrid, Anti-Proliferative Agents, Phosphorylation, threonine, Alzheimer's, anti-proliferative effects, tyrosine kinases, p-glycoprotein, mitochondria, spectrophotometer, tetramethylsilane (TMS), DMEM, DMSO, 3-Thiosemicarbazone, 5-(2-Nitrobenzylidene), 4-Fluorobenzylidene, 4-Hydroxybenzylidene, isopropyl alcohol, ELISA microplate reader, cyclocondensation, NCI ADR Res, benzylidene ring, pharmacological screening, Trivandrum
Medicinal Chemistry
Title: Synthesis and In Vitro Evaluation of Some Isatin-Thiazolidinone Hybrid Analogues as Anti-Proliferative Agents
Volume: 6 Issue: 5
Author(s): P. K. Ramshid, Sankar Jagadeeshan, Anand Krishnan, Mary Mathew, S. Asha Nair and M. Radhakrishna Pillai
Affiliation:
Keywords: Isatin, thiazolidinone, cancer, cytotoxicity, cell cycle arrest, Isatin-Thiazolidinone Hybrid, Anti-Proliferative Agents, Phosphorylation, threonine, Alzheimer's, anti-proliferative effects, tyrosine kinases, p-glycoprotein, mitochondria, spectrophotometer, tetramethylsilane (TMS), DMEM, DMSO, 3-Thiosemicarbazone, 5-(2-Nitrobenzylidene), 4-Fluorobenzylidene, 4-Hydroxybenzylidene, isopropyl alcohol, ELISA microplate reader, cyclocondensation, NCI ADR Res, benzylidene ring, pharmacological screening, Trivandrum
Abstract: A range of isatin-thiazolidinone hybrid analogues were synthesized and their cytotoxicity was evaluated against several cancer cell lines in vitro. The acute toxicity studies in mice models revealed that these analogues possess low systemic toxicity and are safe up to 1600mg/Kg. Among the compounds synthesized, 5-(2-nitrobenzylidene)-2-(isatin-3- azino)-thiazolidin-4-one (CI) has been shown to be the most active, highly promising compound which induced S phase arrest in cell cycle in a time dependent manner. Our initial analysis indicate that incorporation of electron withdrawing group at ortho position of the ring favors over the meta and para positions for eliciting its cytostatic effect. Overall, the in vitro biological evaluation suggests that the growth inhibitory effect of CI is promising and can be studied further.
Export Options
About this article
Cite this article as:
K. Ramshid P., Jagadeeshan Sankar, Krishnan Anand, Mathew Mary, Asha Nair S. and Radhakrishna Pillai M., Synthesis and In Vitro Evaluation of Some Isatin-Thiazolidinone Hybrid Analogues as Anti-Proliferative Agents, Medicinal Chemistry 2010; 6 (5) . https://dx.doi.org/10.2174/157340610793358909
DOI https://dx.doi.org/10.2174/157340610793358909 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Carbohydrates in Computational and Medicinal Chemistry
Carbohydrates are the most essential organic molecules and are involved in the maintenance of various physiological and metabolic processes in living organisms. Carbohydrate-based compounds have come to the attention of researchers because of their significant contributions to biological functions, such as cell development and cell proliferation, connections between several cells, ...read more
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Withdrawal Notice: Application of Nanomaterials in Development of Electrochemical Sensors and Drug Delivery Systems for Anticancer Drugs
Current Drug Delivery Potential Therapeutic Effects of Na+/Ca2+ Exchanger Inhibition in Cardiac Diseases
Current Medicinal Chemistry Exploiting Metabolic Differences in Glioma Therapy
Current Drug Discovery Technologies Mitochondria as Possible Pharmaceutical Targets for the Effects of Vitamin E and its Homologues in Oxidative Stress-Related Diseases
Current Pharmaceutical Design The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
Current Cancer Drug Targets Inhibitory Effect of Ebselen on Cerebral Acetylcholinesterase Activity In Vitro: Kinetics and Reversibility of Inhibition
Current Pharmaceutical Design Development of Novel Therapeutics Targeting the Urokinase Plasminogen Activator Receptor (uPAR) and Their Translation Toward the Clinic
Current Pharmaceutical Design Oncolytic Herpes Simplex Virus Type 1 and Host Immune Responses
Current Cancer Drug Targets Radiolabeled RGD Peptides as Integrin alpha(v)beta3–targeted PET Tracers
Current Medicinal Chemistry Apoptosis Induction by Ultrasound and Microbubble Mediated Drug Delivery and Gene Therapy
Current Molecular Medicine Towards the Molecular Foundations of Glutamatergic-targeted Antidepressants
Current Neuropharmacology Hepatocyte Growth Factor Signaling in Cancer Metastasis
Current Signal Transduction Therapy Astrocyte Signaling and Multiple Sclerosis
Current Signal Transduction Therapy Anticancer Activity of Organogallium(III) Complexes in Colon Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Cytotoxic Effects of Blue Scorpion Venom (<i>Rhopalurus junceus</i>) in a Glioblastoma Cell Line Model
Current Pharmaceutical Biotechnology Angiogenesis Inhibitors and Radiation in Multimodality Cancer Therapy: Preclinical and Clinical Studies
Current Angiogenesis (Discontinued) The Holy Grail of Polymer Therapeutics for Cancer Therapy: An Overview on the Pharmacokinetics and Bio Distribution
Current Drug Metabolism Dendritic Cells in Esophageal Adenocarcinoma: The Currently Available Information and Possibilities to use Dendritic Cells for Immunotherapeutic Approaches
Current Pharmaceutical Design Targeting Glia Cells: Novel Perspectives for the Treatment of Neuropsychiatric Diseases
Current Neuropharmacology Metalloproteinases and Metalloproteinase Inhibitors in Age-Related Diseases
Current Pharmaceutical Design